✦ LIBER ✦

PMH21 THE COST-EFFECTIVENESS OF RISPERIDONE LONG-ACTING INJECTABLE IN SWEDEN

✍ Scribed by J Damen; BMS Heeg; M Lothgren; BA Van Hout

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH5 COST-EFFECTIVENESS OF RISPERIDONE L

✍ Elkis, H; Pereira, M; Kayo, M; Duchesne, I; Alandete, JC 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PMH51 COST-EFFECTIVENESS EVALUATION OF L

✍ J Locklear; N Edwards; MF Rupnow; R Diamond 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMH23 COST-EFFECTIVENESS EVALUATION OF L

✍ N Edwards; M Rupnow; CL Pashos; MF Botteman; J Locklear; R Diamond 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

PMH21 COST-EFFECTIVENESS-ANALYSIS OF RIS

✍ J Skoupá; V Cerna; T Doležl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMH31 Cost-Effectiveness of Long-Acting

✍ T. Dilla; P. O'Donohoe; J. Möller; M. Álvarez; J. Sacristán; L. San; M. Happich; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PMH28 Using Cost-Effectiveness Analysis

✍ A. Valencia-Mendoza; A. Hernández-Garduño 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB